Loading
Latest filing published 16 Sept 2026 for TelyRx Holdings Inc., €1.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Benjamin Atkins discloses dealings in TelyRx Holdings Inc. to SEDI. Between 31 March 2026 and 11 September 2026, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €1.5M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 16 September 2026 with an open-market purchase (€1.5M) in TelyRx Holdings Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations